Perineural dexmedetomidine prolong the duration of analgesia: RCT

Perineural dexmedetomidine prolong the duration of analgesia: RCT - DEX adjuvant local alagesic: RCT

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000026417

Enrollment

Registered

2017-03-06

Start date

2017-03-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

the patients received trunk block

Interventions

0.3% levobupivacaine+dexmedetomidine 1micro g/kg 0.3% levobupivacaine+NS

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 20-75 year old patients

Exclusion criteria

Exclusion criteria: patients intaking coagulation drug severe disease patietns patients we determine as unsuitability

Design outcomes

Primary

Measure	Time frame
first report of postoperative pain at the surgical site	—

Secondary

Measure	Time frame
opioid comsumption, VAS, QOR-40,	—

Countries

Japan

Contacts

Public ContactManbabu Yoshimura

Japan Community Healthcare Organization Tokuyama Central Hospital Department of Anesthesiology

manabu-ygc@umin.ac.jp0834-28-4411

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026